Table 1.
Clinical characteristics of patients with CLL included in the study.
| Patients | Patients (n = 61) | % |
|---|---|---|
| Age | ||
| Years (mean) | 74.8 | |
| Sex | ||
| Female | 24 | 39.3 |
| Male | 37 | 60.6 |
| Rai Stage | ||
| 0 | 35 | 57.3 |
| I–II | 18 | 29.5 |
| III–IV | 8 | 13.1 |
| Binet Stage | ||
| A | 49 | 80.3 |
| B | 6 | 9.8 |
| C | 6 | 9.8 |
| Cytogenetic abnormalities (FISH) | ||
| No alterations | 26 | 42.6 |
| del(13q) | 18 | 29.5 |
| del(11q) | 1 | 1.6 |
| del(17p) | 3 | 4.9 |
| Trisomy 12 | 5 | 8.1 |
| Complex karyotype | 8 | 13.1 |
| IGHV status | ||
| Mutated | 37 | 60.6 |
| Unmutated | 13 | 21.3 |
| Undetermined | 11 | 18 |
| Progression | ||
| Stable disease | 41 | 67.2 |
| Progressive disease | 20 | 32.7 |
IGHV: Variable region of the immunoglobulin heavy chain.